Literature DB >> 22170913

Declining incidence of candidemia in a tertiary inpatient pediatric population.

Kaede V Ota1, Karin L McGowan.   

Abstract

We examined the incidence of candidemia, Candida species distribution, and antifungal susceptibility patterns in a pediatric institution. We identified 301 episodes of candidemia from 2001 to 2010 inclusive. Annual incidence decreased from 0.68 to 0.12 cases/1,000 patient days between 2004 and 2010. Candida albicans was the most common species, followed by C. parapsilosis. All isolates tested were susceptible to amphotericin B and caspofungin, but 11% were resistant or dose-dependently susceptible to fluconazole.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22170913      PMCID: PMC3295117          DOI: 10.1128/JCM.06346-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.

Authors:  Kevin W Garey; Milind Rege; Manjunath P Pai; Dana E Mingo; Katie J Suda; Robin S Turpin; David T Bearden
Journal:  Clin Infect Dis       Date:  2006-05-16       Impact factor: 9.079

2.  Emergence of Candida parapsilosis as the predominant species causing candidemia in children.

Authors:  I Levy; L G Rubin; S Vasishtha; V Tucci; S K Sood
Journal:  Clin Infect Dis       Date:  1998-05       Impact factor: 9.079

3.  Candida non-albicans versus Candida albicans fungemia in the non-neonatal pediatric population.

Authors:  Ankhi Dutta; Debra L Palazzi
Journal:  Pediatr Infect Dis J       Date:  2011-08       Impact factor: 2.129

4.  Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality.

Authors:  Matthew Morrell; Victoria J Fraser; Marin H Kollef
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

5.  Should central venous catheters be removed as soon as candidemia is detected in neonates?

Authors:  M G Karlowicz; L N Hashimoto; R E Kelly; E S Buescher
Journal:  Pediatrics       Date:  2000-11       Impact factor: 7.124

6.  Risk factors for candidemia in a children's hospital.

Authors:  L MacDonald; C Baker; C Chenoweth
Journal:  Clin Infect Dis       Date:  1998-03       Impact factor: 9.079

7.  Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group.

Authors:  J H Rex; J E Bennett; A M Sugar; P G Pappas; J Serody; J E Edwards; R G Washburn
Journal:  Clin Infect Dis       Date:  1995-10       Impact factor: 9.079

8.  Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients.

Authors:  Christopher C Blyth; Sharon C A Chen; Monica A Slavin; Carol Serena; Quoc Nguyen; Deborah Marriott; David Ellis; Wieland Meyer; Tania C Sorrell
Journal:  Pediatrics       Date:  2009-05       Impact factor: 7.124

9.  A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.

Authors:  Peter G Pappas; John H Rex; Jeannette Lee; Richard J Hamill; Robert A Larsen; William Powderly; Carol A Kauffman; Newton Hyslop; Julie E Mangino; Stanley Chapman; Harold W Horowitz; John E Edwards; William E Dismukes
Journal:  Clin Infect Dis       Date:  2003-08-14       Impact factor: 9.079

10.  Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David Andes; Daniel K Benjamin; Thierry F Calandra; John E Edwards; Scott G Filler; John F Fisher; Bart-Jan Kullberg; Luis Ostrosky-Zeichner; Annette C Reboli; John H Rex; Thomas J Walsh; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2009-03-01       Impact factor: 9.079

View more
  3 in total

1.  Central Venous Catheter Retention and Mortality in Children With Candidemia: A Retrospective Cohort Analysis.

Authors:  Brian T Fisher; Neika Vendetti; Matthew Bryan; Priya A Prasad; A Russell Localio; Andreas Damianos; Susan E Coffin; Louis M Bell; Thomas J Walsh; Robert Gross; Theoklis E Zaoutis
Journal:  J Pediatric Infect Dis Soc       Date:  2015-08-16       Impact factor: 3.164

2.  Trends in Pediatric Candidemia: Epidemiology, Anti-Fungal Susceptibility, and Patient Characteristics in a Children's Hospital.

Authors:  Anabel Piqueras; Lakshmi Ganapathi; Jane F Carpenter; Thomas Rubio; Thomas J Sandora; Kelly B Flett; Julia R Köhler
Journal:  J Fungi (Basel)       Date:  2021-01-22

Review 3.  Continuing Shifts in Epidemiology and Antifungal Susceptibility Highlight the Need for Improved Disease Management of Invasive Candidiasis.

Authors:  Ben Y Parslow; Christopher R Thornton
Journal:  Microorganisms       Date:  2022-06-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.